Cargando…
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654918/ https://www.ncbi.nlm.nih.gov/pubmed/26588902 http://dx.doi.org/10.1186/s12889-015-2179-2 |
_version_ | 1782402126190739456 |
---|---|
author | Kharsany, Ayesha BM Cawood, Cherie Khanyile, David Grobler, Anneke Mckinnon, Lyle R. Samsunder, Natasha Frohlich, Janet A Abdool Karim, Quarraisha Puren, Adrian Welte, Alex George, Gavin Govender, Kaymarlin Toledo, Carlos Chipeta, Zawadi Zembe, Lycias Glenshaw, Mary T Madurai, Lorna M Deyde, Varough Bere, Alfred |
author_facet | Kharsany, Ayesha BM Cawood, Cherie Khanyile, David Grobler, Anneke Mckinnon, Lyle R. Samsunder, Natasha Frohlich, Janet A Abdool Karim, Quarraisha Puren, Adrian Welte, Alex George, Gavin Govender, Kaymarlin Toledo, Carlos Chipeta, Zawadi Zembe, Lycias Glenshaw, Mary T Madurai, Lorna M Deyde, Varough Bere, Alfred |
author_sort | Kharsany, Ayesha BM |
collection | PubMed |
description | BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate and inform the programmatic interventions and policies over time. We describe the rationale and design of the HIV Incidence Provincial Surveillance System (HIPSS) to monitor HIV prevalence and incidence. METHODS/DESIGN: The household-based survey will include a sample of men and women from two sub-districts of the uMgungundlovu municipality (Vulindlela and the Greater Edendale) of KZN, South Africa. The study is designed as two sequential cross-sectional surveys of 10,000 randomly selected individuals aged 15–49 years to be conducted one year apart. From the cross sectional surveys, two sequential cohorts of HIV negative individuals aged 15–35 years will be followed-up one year later to measure the primary outcome of HIV incidence. Secondary outcomes include the laboratory measurements for pulmonary tuberculosis, sexually transmitted infections and evaluating tests for estimating population-level HIV incidence. Antiretroviral therapy (ART) access, HIV-1 RNA viral load, and CD4 cell counts in HIV positive individuals will assess the effectiveness of the HIV treatment cascade. Household and individual-level socio-demographic characteristics, exposure to HIV programmatic interventions and risk behaviours will be assessed as predictors of HIV incidence. The incidence rate ratio of the two cohorts will be calculated to quantify the change in HIV incidence between consecutive samples. In anticipation of better availability of population-level HIV prevention and treatment programmes leading to decreases in HIV incidence, the sample size provides 84 % power to detect a reduction of 30 % in the HIV incidence rate between surveys. DISCUSSION: The results from HIPSS will provide critical data regarding HIV prevalence and incidence in this community and will establish whether HIV prevention and treatment efforts in a “real world”, non-trial setting have an impact on HIV incidence at a population level. Importantly, the study design and methods will inform future methods for HIV surveillance. |
format | Online Article Text |
id | pubmed-4654918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46549182015-11-22 Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa Kharsany, Ayesha BM Cawood, Cherie Khanyile, David Grobler, Anneke Mckinnon, Lyle R. Samsunder, Natasha Frohlich, Janet A Abdool Karim, Quarraisha Puren, Adrian Welte, Alex George, Gavin Govender, Kaymarlin Toledo, Carlos Chipeta, Zawadi Zembe, Lycias Glenshaw, Mary T Madurai, Lorna M Deyde, Varough Bere, Alfred BMC Public Health Study Protocol BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate and inform the programmatic interventions and policies over time. We describe the rationale and design of the HIV Incidence Provincial Surveillance System (HIPSS) to monitor HIV prevalence and incidence. METHODS/DESIGN: The household-based survey will include a sample of men and women from two sub-districts of the uMgungundlovu municipality (Vulindlela and the Greater Edendale) of KZN, South Africa. The study is designed as two sequential cross-sectional surveys of 10,000 randomly selected individuals aged 15–49 years to be conducted one year apart. From the cross sectional surveys, two sequential cohorts of HIV negative individuals aged 15–35 years will be followed-up one year later to measure the primary outcome of HIV incidence. Secondary outcomes include the laboratory measurements for pulmonary tuberculosis, sexually transmitted infections and evaluating tests for estimating population-level HIV incidence. Antiretroviral therapy (ART) access, HIV-1 RNA viral load, and CD4 cell counts in HIV positive individuals will assess the effectiveness of the HIV treatment cascade. Household and individual-level socio-demographic characteristics, exposure to HIV programmatic interventions and risk behaviours will be assessed as predictors of HIV incidence. The incidence rate ratio of the two cohorts will be calculated to quantify the change in HIV incidence between consecutive samples. In anticipation of better availability of population-level HIV prevention and treatment programmes leading to decreases in HIV incidence, the sample size provides 84 % power to detect a reduction of 30 % in the HIV incidence rate between surveys. DISCUSSION: The results from HIPSS will provide critical data regarding HIV prevalence and incidence in this community and will establish whether HIV prevention and treatment efforts in a “real world”, non-trial setting have an impact on HIV incidence at a population level. Importantly, the study design and methods will inform future methods for HIV surveillance. BioMed Central 2015-11-20 /pmc/articles/PMC4654918/ /pubmed/26588902 http://dx.doi.org/10.1186/s12889-015-2179-2 Text en © Kharsany et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Kharsany, Ayesha BM Cawood, Cherie Khanyile, David Grobler, Anneke Mckinnon, Lyle R. Samsunder, Natasha Frohlich, Janet A Abdool Karim, Quarraisha Puren, Adrian Welte, Alex George, Gavin Govender, Kaymarlin Toledo, Carlos Chipeta, Zawadi Zembe, Lycias Glenshaw, Mary T Madurai, Lorna M Deyde, Varough Bere, Alfred Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title | Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title_full | Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title_fullStr | Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title_full_unstemmed | Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title_short | Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa |
title_sort | strengthening hiv surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor hiv prevalence and incidence in the umgungundlovu district, kwazulu-natal, south africa |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654918/ https://www.ncbi.nlm.nih.gov/pubmed/26588902 http://dx.doi.org/10.1186/s12889-015-2179-2 |
work_keys_str_mv | AT kharsanyayeshabm strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT cawoodcherie strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT khanyiledavid strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT grobleranneke strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT mckinnonlyler strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT samsundernatasha strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT frohlichjaneta strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT abdoolkarimquarraisha strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT purenadrian strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT weltealex strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT georgegavin strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT govenderkaymarlin strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT toledocarlos strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT chipetazawadi strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT zembelycias strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT glenshawmaryt strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT madurailorna strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT mdeydevarough strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica AT berealfred strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica |